MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UK-12-0001257
Samume Pharmaceutics Private Limited
Samume Pharmaceutics Private Limited - food and beverages in Rudrapur, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.04 Lakh
▼ 7% YoY
Net profit · FY 2025
₹39,039
Net margin 4.3%
EBITDA · FY 2025
₹55,750
EBITDA margin 6.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Samume Pharmaceutics Private Limited
Data last updated:
Samume Pharmaceutics Private Limited is a private limited company based in Rudrapur, Uttarakhand, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 25 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2020PTC011355. Its GSTIN is 05ABECS2760D1ZN (Uttarakhand).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Renu Munjal and Harish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Harish Kumar Indra Colony Road Rdr Teh Kichha, Rudrapur, Uttarakhand, India – 263153.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.04 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹39,039 (net margin 4.3%) and EBITDA of ₹55,750 (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
Samume Pharmaceutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0001257).
Company details
CIN U24304UR2020PTC011355
Registration Number 011355
Incorporation Date 25 August 2020
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UK-12-0001257
Key People
Renu Munjal Director Harish Kumar Director Recognitions & Rankings of Samume Pharmaceutics
Contact details
Samume Pharmaceutics Private Limited's registered office is in Rudrapur, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Harish Kumar Indra Colony Road Rdr Teh Kichha, Rudrapur, Uttarakhand, India – 263153
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Samume Pharmaceutics Private Limited, buy the company report.
Comprehensive company report
Samume Pharmaceutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Samume Pharmaceutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Samume Pharmaceutics Private Limited, buy the company report.
Financials of Samume Pharmaceutics Private Limited
FY 2025 filings availableSamume Pharmaceutics Private Limited reported revenue of ₹9.04 Lakh (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹9.04 Lakh ▼ 7%
Net profit · FY 2025
₹39,039 margin 4.3%
EBITDA · FY 2025
₹55,750 margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 29%
3 years · compounded
▼ 2%
Revenue fell 7% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55,750 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39,039 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samume Pharmaceutics Private Limited, buy the company report.
Board of directors of Samume Pharmaceutics Private Limited
Samume Pharmaceutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Munjal | Director | 25 Aug 2020 | 6 Years 2 Months | Current |
| Harish Kumar | Director | 25 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Samume Pharmaceutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atbu Harita Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | -9.0% | Vyara, Gujarat, India | |||
| Madewell Pharma Private Limited | ₹9.09 Lakh (FY 2025) | 160.0% | Kanpur, Uttar Pradesh, India | |||
| KGR Brothers Manufacturing Private Limited | ₹9.09 Lakh (FY 2021) | 5.0% | Basti, Uttar Pradesh, India | |||
| Platinum Waltech Limited | ₹9.06 Lakh (FY 2021) | -97.0% | New Delhi, Delhi, India | |||
| Pearl Palash Private Limited | ₹9.06 Lakh (FY 2025) | 336.0% | Mumbai, Maharashtra, India | |||
| Samume Pharmaceutics Private Limitedthis company | ₹9.04 Lakh (FY 2025) | ₹39,039 | 4.3% | -7.0% | Rudrapur, Uttarakhand, India | |
| Racee Bio Care Private Limited | ₹9.04 Lakh (FY 2025) | -20.0% | Patna, Bihar, India | |||
| Adya Herbal Private Limited | ₹9.02 Lakh (FY 2024) | -64.0% | Pune, Maharashtra, India | |||
| Outshine Care Solutions Private Limited | ₹9.02 Lakh (FY 2024) | -55.0% | Kozhikode, Kerala, India | |||
| SKM Shree Herbals India Private Limited | ₹9.02 Lakh (FY 2024) | -49.0% | Erode, Tamil Nadu, India | |||
| Indatom Chemicals Private Limited | ₹9.01 Lakh (FY 2024) | 258.0% | Muvattupuzha, Kerala, India |
To see the full peer comparison of Samume Pharmaceutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Samume Pharmaceutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samume Pharmaceutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Samume Pharmaceutics Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Samume Pharmaceutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05ABECS2760D1ZN | Uttarakhand | Active | 31 Aug 2020 |
To see the full GST registrations and return filing status of Samume Pharmaceutics Private Limited, buy the company report.
Recent activity
Samume Pharmaceutics Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Harish Kumar was appointed as Director on 25 Aug 2020.
AGM
Samume Pharmaceutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Samume Pharmaceutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Harish Kumar was appointed as Director.
Appointed
Renu Munjal was appointed as Director.
Incorporation
25 Aug 2020
Samume Pharmaceutics Private Limited was registered on 25 Aug 2020 with Roc Uttarakhand & aged 6 years 2 months as per MCA records.
Frequently asked questions
Samume Pharmaceutics is an active private limited company based in Rudrapur, Uttarakhand, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 25 August 2020 (6+ years old) and is registered under CIN U24304UR2020PTC011355.
Samume Pharmaceutics has 2 current directors:
- Renu Munjal - Director
- Harish Kumar - Director
The latest financial statements of Samume Pharmaceutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Samume Pharmaceutics is 05ABECS2760D1ZN, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Samume Pharmaceutics is U24304UR2020PTC011355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samume Pharmaceutics was incorporated on 25 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Samume Pharmaceutics by revenue are Atbu Harita Pharmaceuticals Private Limited, Madewell Pharma Private Limited, KGR Brothers Manufacturing Private Limited, Platinum Waltech Limited, Pearl Palash Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harish Kumar was appointed as Director on 25 Aug 2020. Renu Munjal was appointed as Director on 25 Aug 2020.
Yes, Samume Pharmaceutics is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-12-0001257).
The registered office of Samume Pharmaceutics is at CO Harish Kumar Indra Colony Road Rdr Teh Kichha, Rudrapur, Uttarakhand, India – 263153.
Samume Pharmaceutics operates in the food and beverages industry, in the manufacturing segment.